iShares US Medical Devices
What to Expect from St. Jude Medical’s Earnings in 2Q16
In 1Q16, St. Jude Medical exceeded analysts’ EPS (earnings per share) estimate of $0.89 as well as the revenue estimate of ~$1.4 billion.
Must-know: Current medical devices risks and opportunities
The industry looks to be weathering the Obamacare storm, yet there are still a couple key reasons to be wary of the industry over the coming months.
Why medical device companies’ federal contracts will boost stocks
A group of medical device manufacturers was recently awarded a slew of government contracts for devices, equipment, and supplies.
Most Analysts Rate Boston Scientific a ‘Buy’
Based on the recommendations of 27 brokerage firms in a Bloomberg survey, about 78% gave Boston Scientific a consensus rating of “buy.”
Varian Medical Systems’ Oncology Devices Are Key to Sales Growth
Varian Medical Systems commands the majority share of the oncology device market in the United States.
Analysts Recommend Boston Scientific as a Strong ‘Buy’
Boston Scientific will release its 1Q16 earnings results on April 27. In a survey of 28 brokerage firms, about 78.6% of the firms rated Boston Scientific as a “buy.”
Is ROP’s Medical Device Segment the Biggest in Healthcare?
Going forward, both research and development and sales and supply chain strategies will play crucial roles for Roper Technologies (ROP) and its peers.
ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain
On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.
Zimmer Biomet Stock Regains Momentum: What’s Driving Growth?
Ximmer Biomet (ZBH) has risen 2.1% since its 1Q17 earnings release on April 27, 2017. The results exceeded analysts’ estimates, but ZBH lowered its 2017 guidance.
Abbott Laboratories Traded at a 52-Week High after Posting Strong 4Q17 Results
On January 29, 2018, Abbott Laboratories (ABT) closed trading at $63.31 per share. The company reported its 52-week high of $64.60 on January 25.
Analysts’ Latest Recommendations for Baxter: Mostly ‘Holds’
Let’s look at Wall Street analysts’ recommendations and target prices for Baxter International (BAX) over the next 12 months.
ABT’s Recent Stock Slump: What’s behind the Decline?
On May 2, Abbott Laboratories (ABT) ended trading at a closing price of $58.14 per share.
How Are Stryker’s Core Strategies Working Toward Its Growth?
Stryker (SYK) registered strong 3Q16 earnings on October 27, 2016. The company’s reported earnings exceeded analysts’ estimates.
BSX Stock Up on Strong Q2 2018 Results, Beats Estimates
Boston Scientific (BSX) announced its Q2 earnings on July 25. BSX reported sales of $2.49 billion, up ~10.3% year-over-year.
BD’s Stock Price Performance after Recent 52-Week High
On December 28, Becton, Dickinson and Company (BDX), or BD, closed trading on the day at $214.32 per share. Currently, BD stock’s 50-day moving average stands at $221.22.
Discussing Boston Scientific’s Stock Performance in 2018 So Far
On July 9, Boston Scientific (BSX) stock ended the trading day at $33.79, a rise of ~0.50% compared to the previous day.
Abbott Laboratories’ Stock Performance after a Recent Bull Run
On February 16, Abbott Laboratories (ABT) closed trading at $60.17 per share.
Abbott Laboratories’ Stock Price Performance in July
Year-to-date, ABT stock has risen 12.8%. Over the last month, the stock has returned ~4.0%.
Can BAX Stock Maintain Momentum after Recent Highs?
BAX stock plummeted in late 2016 but has witnessed a rise in recent months, trading at a 52-week high on October 27, 2017.
Eclipse System Expands Varian’s Market Presence in Australia
On December 12, Varian announced that the Peter MacCallum Cancer Centre in Melbourne had selected its Eclipse treatment planning system for the replacement of its existing platform.
How Edwards Lifesciences Trades Compared to Its Peers
As of August 30, 2016, Edwards Lifesciences (EW) was trading at a forward PE (price-to-earnings) multiple of 40x.
How Has Boston Scientific Stock Performed Recently?
Boston Scientific (BSX) was trading at $27.9 on June 29, 2017.
BSX Stock Regains Momentum after Its Recent Bearish Trend
On February 14, 2018, Boston Scientific stock closed the day at $26.81. The stock was trading near its 50-day moving average of $26.82.
ZBH Stock Price Momentum Likely to Trend Upward
On January 24, Zimmer Biomet Holdings (ZBH) closed trading at a share price of $125.02. The company traded at a 52-week high of $133.49 on July 17, 2017.
Stryker’s Recent Stock Price Movement: Upside Potential?
Stryker stock has registered slightly volatile activity in the past few months. However, the stock largely remains on a bullish trajectory.
A Look at Medtronic’s Recent Stock Performance
Medtronic (MDT) was trading at $83.9 on May 22, 2017. It had a 50-day moving average of $82.1 and a 200-day moving average of $78.4.
Effect of Claris Injectables Acquisition on Baxter’s 2017 Growth
On July 27, 2017, Baxter International (BAX) completed the acquisition of Claris Injectables, which is expected to help expand and strengthen Baxter’s core capabilities.
Must-know: Key export barriers for medical device manufacturers
Most large U.S. manufacturers have invested significant capital into emerging markets, including Medtronics, Johnson & Johnson, GE, and Stryker.
How Has Thermo Fisher Scientific’s Stock Performed Recently?
Thermo Fisher Scientific (TMO) was trading at $140.3 on November 28, 2016.
Waters Introduces Symphony, Its New Data Pipeline Software
A top IHI performer on June 2, 2016, was Waters (WAT), which rose 0.9%. The company was in the news with the introduction of its new data pipeline software.
How Has Varian Medical Systems Stock Been Performing Recently?
On December 22, Varian Medical Systems closed the trading day at a price of $110.9. The stock closed 0.18% higher on the day compared to the previous day’s close.
How Did STERIS Perform in a Competitive Market?
The PE ratios of STERIS, Stryker Corporation, Ecolab, Hill-Rom Holdings, and Cantel Medical are 33.46x, 31.05x, 29.64x, 37.37x, and 51.55x, respectively.
What to Expect from Medtronic’s Diabetes Segment
In September 2018, Medtronic (MDT) announced that the company would acquire all outstanding shares of Mazor Robotics (MZOR) for $58.50 per American depository share.
St. Jude Medical: Key strategic stock outlook
Laser focus CEO Dan Starks told an audience last week that excessive focus on emerging markets “fails to appreciate the potential of the medical device industry.” The CEO firmly believes that straying into emerging markets implies a lack of imagination and focus. This is highly controversial, as most medical technology giants have been investing significantly […]
Anacor Stayed Positive among the Hammered Mid-Caps
Anacor Pharmaceuticals (ANAC) was one of the top mid-cap performers for the week. It rose by 5.9% for the week. The stock rose due to good trading volumes.
A Closer Look at IHI’s Mid-Cap Performances
Varian Medical Systems (VAR) rose by 0.4% on May 12, 2016. Varian has a weight of ~1.8% in IHI’s portfolio.
Assessing Abbott’s 3Q17 Expectations by Segment
In 3Q17, the Established Pharmaceuticals segment of Abbott Laboratories is expected to report high double-digit operational sales growth.
Wall Street Analysts Are Mostly Positive on Abiomed
On November 26, Abiomed (ABMD) stock closed at $311.15, a ~3.92% rise from its previous day’s close of $299.41 on November 23.
Illumina Stock Continues Its Bull Run
Illumina (ILMN) reached a 52-week high of $357.93 per share on August 31.
Brazil’s medical device industry: Health coverage outlook
The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.
What Can We Expect for Stryker’s Earnings in 2Q16?
In 1Q16, Stryker exceeded analysts’ EPS (earnings per share) estimate of $1.20, as well as the revenue estimate of ~$2.5 billion.
Sharpe ratio shows healthcare ETFs are a strong relative investment
Adjusting performance on a risk basis As new insurees flood the insurance market and baby boomers approach retirement, the healthcare space should expect dramatic increases in demand. Alongside an increase in demand, however, has been a tightening of reimbursement policy and a more stringent regulatory environment. These variables present unique risks and opportunities for healthcare […]
What’s Driving TransEnterix Stock on January 8?
On January 8, TransEnterix (TRXC) rose 11.15% compared to its previous closing price and reached $2.99 in its pre-market trading session.
A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019
Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018.
How Does Medtronic’s Restorative Therapies & Diabetes Group Look?
Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty and Pain therapies.
Why Analysts Are Mostly Positive on Boston Scientific Stock
Boston Scientific stock rose from $24.79 at the close of market on December 29, 2017, to $34.80 at the close of market on November 23.
Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date
Intuitive Surgical’s stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018.
Inside General Electric’s Healthcare Business Unit Spin-Off Plan
As part of its major restructuring plan, General Electric (GE) intends to spin off its Healthcare segment and turn it into a standalone entity.
Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings
Thermo Fisher Scientific (TMO) reported its third-quarter results today. It surpassed analysts’ estimates for EPS and revenue.
Thermo Fisher’s Third-Quarter Revenue Estimates
The Life Sciences Solutions segment, including reagents, instruments, and consumables, contributes ~25% of Thermo Fisher’s total revenues.
Zimmer Biomet Holdings: Revenue Trends ahead of Its Q3 Earnings
Zimmer Biomet (ZBH) plans to release its Q3 earnings on October 26. Analysts expect ZBH to generate third-quarter revenues of $1.8 billion.
EW Stock Returned More than the S&P 500’s Gain in 2018
As of September 28, Edwards Lifesciences (EW) has registered a rise of ~52.5% YTD (year-to-date). In the same period, the S&P 500 has risen ~9.2%.
ABT Returns Almost Double the S&P 500’s Year-to-Date Gain
As of September 19, Abbott Laboratories (ABT) has registered a rise of ~17% YTD (year-to-date).
How Thermo Fisher Scientific’s Valuation Looks in September
Thermo Fisher Scientific currently trades at a forward PE multiple of ~19.9x.
Medical Device ETFs: Much Higher YTD Returns in 2018
The iShares U.S. Medical Devices ETF (IHI) and the SPDR S&P Health Care Equipment ETF have returned 26.8% and $37%, respectively, YTD.
What Analysts Expect for Abiomed
Wall Street analysts estimate Abiomed (ABMD) will report 29.9% growth in revenues to ~$771.0 million in 2019 as compared to $593.7 million in 2018.
What’s Driving Boston Scientific Stock Upward
On April 3, 2018, Boston Scientific stock closed at $27.46, up ~2.3% from the previous day.
How TMO Stock Has Performed Recently
On March 14, 2018, Thermo Fisher Scientific (TMO) closed at $213.46 per share.
Reading Dentsply Sirona’s Recent Stock Performance
On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.
BSX Stock Rises More Than 2% Following EMcision Acquisition
Boston Scientific’s recent stock performance On March 6, 2018, Boston Scientific (BSX) stock closed at $27.41, higher than its 50-day moving average of $27.15 and lower than its 200-day moving average of $27.52. As of March 7, 2018, Boston Scientific’s 52-week high was $29.93 on October 23, 2017, and its 52-week low was $24.02 on March 22, 2017. Factors […]
Where Is SYK Stock Headed after Its Recent All-Time Highs?
On February 26, 2018, Stryker (SYK) closed trading at $165.77. The stock was trading at its all-time high of $170 on January 29, 2018.
What Analysts Recommend for Medtronic ahead of 3Q18 Earnings
Medtronic (MDT) plans to release its 3Q18 earnings results on February 20, 2018.
How BD Stock Has Performed in the Last Year
On February 6, 2018, BD released its 1Q18 earnings results, which came in ahead of expectations.
BD Medical Segment Posted Strong Fiscal 1Q18 Performance
In fiscal 1Q18, BDX’s Medication and Procedural Solutions business registered sales growth of 5.0%.
Rationale behind Varian Medical’s Acquisition of Sirtex Medical
On January 30, 2018, Varian Medical Systems (VAR) announced that it had entered into an agreement to acquire Sirtex Medical Limited for $1.3 billion.
ABT Stock Trading Near Its All-Time High: What’s Driving Growth?
Abbott Laboratories (ABT) is currently trading near its all-time high of $59.60 per share, which was reported on January 4, 2018.
Stryker’s Latest Valuation Metrics
As of January 9, Stryker International (SYK) was trading at a PE ratio of 34.3x and 12-month forward PE (price-to-earnings) ratio of 22.4x. So the company’s earnings are expected to grow over the next year.
Stryker’s Stock Rally Continues with 52-Week High Yesterday
On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4.
Discussing Baxter International’s Recent Stock Price Highs
On January 4, 2018, Baxter International was trading at a 52-week high of $68.86 per share, ending the day at $68.41 per share.
A Look at Thermo Fisher Scientific’s Recent Stock Price Performance
TMO stock reported its 52-week high of $201.20 on October 26, 2017, when the company released its 3Q17 earnings results.
TMO’s Acquisition from EPTEK Technology Could Boost Its China Opportunity
On December 4, 2017, Thermo Fisher Scientific (TMO) completed the acquisition of some assets from EPTEK Technology and related entities that have offices in mainland China and Taiwan.
Boston Scientific’s Latest Valuation Metrics
As of December 19, 2017, Boston Scientific (BSX) was trading at a 12-month forward PE (price-to-earnings) ratio of 18.4x.
Boston Scientific Stock: Triggered by Recent Developments
Boston Scientific (BSX) stock closed at $25.80 on December 18, 2017. It was trading lower than its 50-day moving average of $27.10 as well as its 200-day moving average of $27.80.
How the Corporate Tax Rate Cut Could Affect R&D in the Medtech Industry
The repeal of the tax deduction for high medical expenses may reduce the number of taxpayers opting for costly medical technologies and services.
Medtronic’s Recent Stock Price Performance
On June 26, 2017, Medtronic reported its 52-week high of $89.70, while the company’s 52-week low stood at $69.30 on January 3, 2017.
Varian’s Halcyon System Sees Strong Global Growth Momentum
Varian Medical Systems (VAR) received FDA (U.S. Food & Drug Administration) approval in June 2017 for its Halcyon system.
Understanding BD’s Recent Stock Performance
BD has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.
How Has ZBH Stock Performed Recently?
Zimmer Biomet Holdings (ZBH) has fallen around 0.8% over the last one week.
Inside Baxter International’s Stock Price Performance
On September 7, 2017, BAX stock closed at $62.84 per share. It has a 50-day moving average of $61.15 and a 200-day moving average of $57.14.
Edwards Lifesciences Near 52-Week High: Can It Sustain Momentum?
Edwards Lifesciences (EW), a leader in the artificial heart valve market, has been expanding rapidly amid its new product launches and innovative product pipeline.
Boston Scientific Is Accelerating Category Leadership Strategy
Boston Scientific (BSX) currently has a global market opportunity of $40.0 billion, which is expected to grow to $50.0 billion by fiscal 2020.
What’s Behind the Recent Slump in ZBH Stock Price?
Zimmer Biomet closed trading at price of $113.1 on August 30. The stock has a 50-day moving average of $119.95 and a 200-day moving average of $120.95.
Taking a Look at Stryker’s Recent Stock Price Performance
On August 31, Stryker (SYK) closed trading at a closing price of $139.3. It has a 50-day moving average of $144.7 and a 200-day moving average of $137.5.
How Medtronic Is Accelerating Its Economic Value Growth Strategy
Medtronic’s (MDT) Hospital Solutions segment registered double-digit growth in fiscal 1Q18.
Analysts’ Recommendations for Varian Medical Systems
With the spin-off of its Imaging Components business, Varian Medical Systems (VAR) is now more aligned with its core capabilities. In this series, we’ll discuss the company’s dynamics after the Varex spin-off.
Key Highlights of Varian Medical Systems’ Fiscal 2Q17 Earnings
On April 26, 2016, Varian Medical Systems (VAR) released its 2Q17 earnings. VAR beat consensus estimates for revenues in 2Q17 by ~0.8% and reported in-line earnings per share.
Key Drivers behind BDX’s Recent Stock Performance
BDX has a 50-day moving average of $196.80 and a 200-day moving average of $185.70.
What to Expect from Intuitive Surgical’s 2Q17 Earnings
Analysts estimate that Intuitive Surgical will post 2Q17 EPS (earnings per share) of ~$4.76. In 1Q17, Intuitive Surgical exceeded analysts’ diluted EPS estimate of $4.67.
Behind BD’s Recent New Stock Price High
BD (BDX) closed trading at $195.3 on July 6, 2017, ahead of its 50-day moving average of $191.3 and its 200-day moving average of $181.9.
A Look at Abbott Laboratories Stock for 2Q17
Wall Street analysts estimate that Abbott Laboratories (ABT) stock has the potential to return ~6.1% over the next 12 months.
Varian Medical Systems: Analyzing Its Stock Performance
Varian Medical Systems (VAR) was trading at $102.7 on June 29, 2017. It has a 50-day moving average of $100.4 and a 200-day moving average of $88.8.
FDA Warning Letter to Zimmer Biomet Resolved, Boosts Confidence
On June 13, 2017, Zimmer Biomet (ZBH) announced that the FDA warning letter issued in June 2015 relating to its Zhejiang manufacturing facility in China has been closed.
Health Sector Overview: Week of June 5–9, 2017
In the week ending June 9, 2017, the Health Care Select Sector SPDR Fund (XLV) saw a rise of 0.13%.
Behind Thermo Fisher’s Recent Stock Performance
TMO stock was trading at $173.2 on May 30, 2017. The stock had a 50-day moving average of $165.9 and a 200-day moving average of $153.8 that day.
How Zimmer Biomet Stock Has Performed Recently
Zimmer Biomet Holdings (ZBH) was trading at $118.40 on May 30, 2017. It has a 50-day moving average of $119.70 and a 200-day moving average of $114.20.
Medtronic’s Strong 4Q17 Profits Beat Analyst Expectations
Medtronic (MDT) reported an operating margin of 30.7% of total sales in fiscal 4Q17 on a constant currency basis.
Discussing Edwards Lifesciences’ Recent Stock Movements
Edwards Lifesciences (EW) is a leading company in the artificial heart valve market, and it’s the largest player in the TAVR (transcatheter aortic valve replacement) market.
What Do Analysts Recommend for Boston Scientific?
Let’s look at Wall Street analysts’ recommendations and target prices for Boston Scientific (BSX) over the next 12 months.
Trump Trade Fades amid Political Debacle: What’s the Impact?
As part of Obamacare, a medical device tax of 2.3% has been implemented on medical device companies in the United States.
Behind Boston Scientific’s Recent Stock Performance
Boston Scientific (BSX) was trading at $26.35 on May 4, 2017, as compared to its 50-day moving average of $24.93 and its 200-day moving average of $23.38.